NewAmsterdam Pharma
NAMS
NAMS
167 hedge funds and large institutions have $3.94B invested in NewAmsterdam Pharma in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 48 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
9% less funds holding
Funds holding: 184 → 167 (-17)
31% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 35
38% less call options, than puts
Call options by funds: $11M | Put options by funds: $17.7M
Holders
167
Holding in Top 10
8
Calls
$11M
Puts
$17.7M
Top Buyers
| 1 | +$76.6M | |
| 2 | +$71.8M | |
| 3 | +$36.6M | |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$25.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$19.6M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$24.1M | |
| 3 | -$20.2M | |
| 4 |
FTM
First Turn Management
Del Mar,
California
|
-$10.9M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$9.78M |
